VENLO, The Netherlands, June 8, 2016 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its decision to change the offer conditions for the acquisition of shares in Exiqon A/S, reducing the threshold from 90% to 89.20%. All other terms and conditions remain unchanged. In line with the Danish Takeover Order, which requires the extension of an offer period in case of changing offer terms and conditions, QIAGEN N.V. is further extending the offer period, which will now expire on 22 June 2016 at 23:59 (CET).

On 3 June 2016, QIAGEN N.V. had extended the conditional voluntary offer and announced that the Company has already received acceptances representing 89.21% of the share capital and voting rights in Exiqon.

In addition to the acceptances received and as described in the Offer Document, QIAGEN N.V. had also announced that members of the Executive Management in aggregate hold 4,021,959 warrants in Exiqon which are convertible into the same number of Exiqon shares (just below 1% of outstanding shares following conversion). Such warrants are expected to vest immediately upon Completion, if any, of the Offer and can either be settled in cash or in shares depending on the decision by Exiqon's Board of Directors.

Click here [https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=%7b8D82220F-387A-4903-A9A6-BA68406F16F5%7d&lang=en ] for full press release 


        
         
        Contacts: 
        Public Relations: 
        Dr. Thomas Theuringer 
        Senior Director Public Relations 
        +49-2103-29-11826 
        Email: pr@qiagen.com 
        EmptyBreak:MARKER 
        http://www.twitter.com/qiagen  
        https://www.facebook.com/QIAGEN  
        pr.qiagen.com 
        EmptyBreak:MARKER 
        Investor Relations: 
        John Gilardi 
        Vice President Corporate Communications and Investor Relations 
        +49-2103-29-11711 
        Email: ir@qiagen.com  
        ir.qiagen.com 

 

SOURCE QIAGEN N.V.